Adverum Faces Rocky Road As It Switches Gears From DME To Wet AMD
Gene Therapy Company Calls Off Diabetic Macular Edema Program
Adverum is shifting the focus of its gene therapy from DME to wet AMD, but it faces a challenging path forward • Source: Shutterstock 
